CTXR
#4633
Citius Pharmaceuticals, Inc. - Common Stock
0.6 0 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.64%
Monthly Change
+5.26%
6 month change
-14.29%
Year Change
-53.85%
Previous Close
0.6 1
Open
0.6 0
Low
0.6 0
High
0.6 0
Volume
5
Financials
- Market Capitalization 16.47 M
- Employee 23
- Founded 2007
- CEO N/A
- Website www.citiuspharma.com
- Headquarter Nevada, United States
- FIGI BBG001QQH2N3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4620 |  LEXX Lexaria Bioscience Corp. - Common Stock | 10.37 USD | -11.22% | -5.38% | +1894.23% | +1065.17% | 17.14 M USD | ||
| 4632 |  PLUR Pluri Inc. - Common Stock | 1.53 USD | 0.00% | -10.53% | -3.77% | -59.97% | 16.51 M USD | ||
| 4640 |  BIVI BioVie Inc. - Common stock | 2.16 USD | -1.37% | +19.34% | +66.15% | +71.43% | 16.29 M USD | ||
| 4651 |  CALC CalciMedica, Inc. - Common Stock | 0.46 USD | -2.13% | -20.69% | -39.47% | -83.21% | 15.71 M USD |
Frequently asked questions about Citius Pharmaceuticals Inc. Common
What is the Citius Pharmaceuticals Inc. Common stock price today?
The current price of Citius Pharmaceuticals Inc. Common (CTXR) is 0.60. Over the past 24 hours, the stock has changed by -1.64%. Follow the CTXR chart for real-time price dynamics.
What is the stock ticker of Citius Pharmaceuticals Inc. Common?
Citius Pharmaceuticals Inc. Common trades under the ticker CTXR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Citius Pharmaceuticals Inc. Common stock going up?
CTXR has changed by -1.64% over the last week, +5.26% over the last month, and -53.85% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Citius Pharmaceuticals Inc. Common?
Citius Pharmaceuticals Inc. Common currently has a market capitalization of 16.47 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Citius Pharmaceuticals Inc. Common earnings last quarter?
Last quarter, Citius Pharmaceuticals Inc. Common reported earnings of -0.34 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Citius Pharmaceuticals Inc. Common revenue for the last quarter?
Citius Pharmaceuticals Inc. Common reported quarterly revenue of 1.49 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Citius Pharmaceuticals Inc. Common net income for the last quarter?
Citius Pharmaceuticals Inc. Common reported net income of -11.92 M for the last quarter. The previous quarter showed -28.11 M, which means net income changed by +57.60%.
How many employees does Citius Pharmaceuticals Inc. Common have?
As of the latest available data, Citius Pharmaceuticals Inc. Common has 23 employees. Workforce size can provide additional context about the company's scale and operations.
What is Citius Pharmaceuticals Inc. Common EBITDA?
Citius Pharmaceuticals Inc. Common EBITDA is -11.55 M, and its EBITDA margin is -773.37%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Citius Pharmaceuticals Inc. Common stock?
You can buy Citius Pharmaceuticals Inc. Common (CTXR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Citius Pharmaceuticals Inc. Common stock?
Investing in Citius Pharmaceuticals Inc. Common requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CTXR chart and related analysis on metatrader.com as part of your research.